Bengaluru: The Karnataka High Court has refused to quash a prosecution against a pharmaceutical firm and its managing partner under Sections 18(a)(i) and 27(d) of the Drugs and Cosmetics Act, 1940, holding that the expression “forthwith” in Section 23(4)(i) of the Act does not mean that a seized drug sample must be sent for analysis immediately on seizure, and that a delay of two days was neither undue nor unexplained.
Justice Rajesh Rai K. was hearing Crl.P. No. 1600 of 2024 under Section 482 CrPC filed by M/s Life Vision Healthcare, Baddi, Himachal Pradesh, and its Managing Partner, Naveen Kumar Bansal, seeking to quash C.C. No. 43/2023 pending before the Special Court for Economic Offences, Bengaluru. The respondent was the State, at the instance of the Assistant Drugs Controller, Bengaluru Circle-1, who had filed a private complaint under Section 200 CrPC.
The complaint alleges that the firm manufactured and marketed ‘Impcal Tablets’ (Calcium Orotate with Vitamin D3 Tablets I.P.), Batch No. LTA-2497, manufactured in September 2019 and expiring in February 2021, which was reported as ‘Not of Standard Quality’ on analysis. A legal sample was drawn from a Bengaluru establishment on 18.02.2020 and sent for analysis on 20.02.2020. The report of 24.08.2020 found it substandard on the parameter ‘Assay for Vitamin D3’. On 25.08.2020, notice under Sections 18A and 18B was issued to the retailer, who disclosed that he had bought the drug from the petitioners.
The petitioners argued that the Magistrate took cognizance without applying his mind and that Section 23(4)(i) was breached because the sample was not forwarded “forthwith”. They also argued that the complaint was filed after the shelf life had expired, depriving them of the right to seek re-analysis by the Central Drugs Laboratory under Sections 25(3) and 25(4), and that the Managing Partner could not be prosecuted merely on account of his position without specific allegations. They relied on Medicamen Biotech Ltd. v. Rubina Bose (2008) 7 SCC 196, State of Punjab v. National Organic Chemical Industries Ltd. (1996) 11 SCC 613, Inox Air Products Ltd. v. State of A.P. (2025 SCC OnLine SC 209) and Lalankumar Singh v. State of Maharashtra (2022 SCC OnLine SC 1383). The State submitted that the delay was justified and that the Analyst’s report made out a prima facie case.
On the sample, the Court held:
“The expression ‘forthwith’ employed under Section 23(4)(i) of the Drugs and Cosmetics Act, 1940, cannot be construed to mean that the seized drug sample must necessarily be forwarded for chemical analysis immediately upon its seizure, without undertaking the other procedural steps contemplated under the provisions of the said Act.”
It reasoned that the authorities must first seize the sample and issue the requisite notice to the retailer before forwarding it, so that the two-day gap was not an undue or unexplained delay.
On re-analysis, the Court noted that the petitioners had been informed of the ‘Not of Standard Quality’ result by communication dated 28.08.2020, but sought re-analysis only by letter dated 15.04.2021, after nearly eight months and after the shelf life had expired in February 2021. The request was belated, and the inability to re-analyse the sample could not, on the material available, be attributed to any lapse by the authorities.
On the Managing Partner, the Court noted that the petitioners placed no cogent material to show that he was not concerned with the day-to-day affairs of the firm, whereas the complaint prima facie indicated active involvement. The judgments relied on were held to be distinguishable on facts.
Holding that the allegations, if established, have a direct bearing on public health and cannot be lightly brushed aside at this stage, the Court said the matter warrants a full trial and dismissed the petition without expressing any opinion on the merits, leaving the petitioners at liberty to raise all contentions before the Magistrate during trial.
Appearances:
For the Petitioners: Mr. Nitin Bhasir and Mr. Uday Urs, Advocates.
For the Respondent: Mr. Mahesha P., High Court Government Pleader.
Case Title: M/s Life Vision Healthcare & Anr. vs. State at the instance of Asst. Drugs Controller, Bengaluru Circle-1, Crl.P. No. 1600 of 2024, 2026:KHC:60798
